United States
Germany
Japan
United Kingdom
China
BIRC3 (cIAP2) mouse monoclonal antibody, clone OTI3G4 (formerly 3G4)
| Applications | FC, WB |
| Reactivities | Human |
Antibodies
BIRC3 (cIAP2) mouse monoclonal antibody, clone OTI1A9 (formerly 1A9)
| Applications | FC, WB |
| Reactivities | Human |
BIRC3 (cIAP2) mouse monoclonal antibody, clone OTI2B2 (formerly 2B2)
| Applications | WB |
| Reactivities | Human |
BIRC3 (cIAP2) mouse monoclonal antibody, clone OTI1D12 (formerly 1D12)
| Applications | IF, WB |
| Reactivities | Human |
BIRC3 (cIAP2) mouse monoclonal antibody, clone OTI2G7 (formerly 2G7)
| Applications | WB |
| Reactivities | Human |
BIRC3 (cIAP2) mouse monoclonal antibody, clone OTI2B7 (formerly 2B7)
| Applications | WB |
| Reactivities | Human |
BIRC3 (cIAP2) mouse monoclonal antibody, clone OTI1F5 (formerly 1F5)
| Applications | WB |
| Reactivities | Human |
BIRC3 (cIAP2) mouse monoclonal antibody, clone OTI1E3 (formerly 1E3)
| Applications | WB |
| Reactivities | Human |
BIRC3 (cIAP2) mouse monoclonal antibody, clone OTI3G4 (formerly 3G4)
| Applications | FC, WB |
| Reactivities | Human |
BIRC3 (cIAP2) mouse monoclonal antibody, clone OTI2B2 (formerly 2B2)
| Applications | WB |
| Reactivities | Human |
BIRC3 (cIAP2) mouse monoclonal antibody, clone OTI1A9 (formerly 1A9)
| Applications | FC, WB |
| Reactivities | Human |
BIRC3 (cIAP2) mouse monoclonal antibody, clone OTI1D12 (formerly 1D12)
| Applications | IF, WB |
| Reactivities | Human |
BIRC3 (cIAP2) mouse monoclonal antibody, clone OTI1E3 (formerly 1E3)
| Applications | WB |
| Reactivities | Human |
BIRC3 (cIAP2) mouse monoclonal antibody, clone OTI2B7 (formerly 2B7)
| Applications | WB |
| Reactivities | Human |
BIRC3 (cIAP2) mouse monoclonal antibody, clone OTI2G7 (formerly 2G7)
| Applications | WB |
| Reactivities | Human |
